13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis

Hepato-Gastroenterology

Volumn 47, Issue 31, 2000, Pages 234-238

  Fasoli, A ^b   Giannini, E ^b   Botta, F ^b   Romagnoli, P ^b   Risso, D ^b   Celle, G ^b   Testa, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

Aminopyrine; Breath test; Cirrhosis; Liver function; MEGX

Indexed keywords

AMINOPHENAZONE; CARBON 13; CYTOCHROME P450; DEETHYLLIDOCAINE; LIDOCAINE; CARBON; CARBON DIOXIDE; DIAGNOSTIC AGENT;

ADULT; AGED; AIR SAMPLING; ARTICLE; BREATH ANALYSIS; CARBON DIOXIDE EXCRETION; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG METABOLISM; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; AREA UNDER THE CURVE; COMPARATIVE STUDY; HEPATITIS B; HEPATITIS C; LIVER FUNCTION TEST; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ADULT; AMINOPYRINE; AREA UNDER CURVE; BREATH TESTS; CARBON DIOXIDE; CARBON RADIOISOTOPES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIDOCAINE; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 0033627970     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 14C]Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis. Dig Dis Sci 1985; 30:813-818.
2. 2 George J, Murray M, Byth K, Farrell GC: Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995; 21:120-128.
3. 3 Branch RA: Drugs as indicators of hepatic function. Hepatology 1982; 2:97-105.
4. 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis. N Engl J Med 1974; 291:1384-1388.
5. 2 breath analysis as a measurement of demethylation of stable isotope labeled aminopyrine in man. Clin Chim Acta 1978; 84:153-162.
6. 6 Merkel C, Bolognesi M, Bellon S, Bianco S, Honisch B, Lampe H, et al: Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 1992; 33:836-842.
7. 7 Merkel C, Morabito A, Sacerdoti D, Bolognesi M, Angeli P, Gatta A: Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol 1998; 30:276-282.
8. 8 Irving CS, Schoeller DA, Nakamura KI, Baker AL, Klein PD: The aminopyrine breath test as a measure of liver function. A quantitative description of its metabolic basis in normal subjects. J LaB Clin Med 1982; 100:356-373.
9. 9 Bargetzi MJ, Aoyama T, Gonzales FJ, Meyer UA: Lidocaine metabolism in human liver microsomes by cytochrome P450-IIIA4. Clin Pharmacol Ther 1989; 46:521-527.
10. 2 breath test. In: Paust H, et al (Eds.). Klinische Ernãhrung, vol.34. München: W Zuckschwerdt Verlag, 1988; pp. 52-61.
11. 11 Houston JB, Lockwood GF: Aminopyrine demethylation kinetics: comparison of plasma and exhaled metabolites. Br J Pharmacol 1979; 66:429P.
12. 2-Breath Tests at the laboratory "Digestion-absorption". University Hospital. Belgium: Gasthuisberg Leuven, May 1996; pp. 43-54.
13. 13 Villeneuve JP, Infante-Rivard C, Ampelas M, Pomrier-Layrargues G, Huet PM, Marleau D: Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology 1986; 6:928-931.
14. 14 Haycock G, Shwartz G, Wisotsky D: Geometric method for measuring body surface area. J Pediatr 1978; 93:62-66.
15. 15 Testa R, Campo N, Caglieris S, Risso D, Alvarez S, Arzani L, Giannini E, Lantieri PB, Celle G: Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis. Hepatogastroenterology 1998; 19:154-159.
16. 16 Brockenmöller J, Roots I: Assessment of liver metabilic function. Clin Pharmacokinet 1994; 27:216-248.
17. 17 Schoeller DA, Baker AL, Monroe PS, Krager PS, Schneider JF: Comparison of different methods of expressing results of the aminopyrine breath test. Hepatology 1982; 2:455-462.
18. 14C acid levels in liver function and disease. Dig Dis Sci 1992; 37:1655-1660.
19. 13C-breath test for quantitative assessment of liver function in humans. Hepatogastroenterology 1995; 42:931-938.
20. 20 Schneider JF, Baker AL, Haines NW, Hatfield G, Boyer JL: Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology 1980; 79:1145-1150.
21. 21 Huet PM, Villeneuve JP: Determinants of drug disposition in patients with cirrhosis. Hepatology 1983; 3:913-918.
22. 13C-aminopyrine breath test. International congress on clinical application of breath tests in gastroenterology and hepatology. Roma 1988; pp. 23-24.